89 related articles for article (PubMed ID: 17900631)
1. Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas.
Yang J; Zhou F; Xu T; Deng H; Ge YY; Zhang C; Li J; Zhuang SM
Mutat Res; 2008 Feb; 638(1-2):205-9. PubMed ID: 17900631
[TBL] [Abstract][Full Text] [Related]
2. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.
Li Y; Tan W; Neo TW; Aung MO; Wasser S; Lim SG; Tan TM
Cancer Sci; 2009 Jul; 100(7):1234-42. PubMed ID: 19486339
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.
Wu M; Jolicoeur N; Li Z; Zhang L; Fortin Y; L'Abbe D; Yu Z; Shen SH
Carcinogenesis; 2008 Sep; 29(9):1710-6. PubMed ID: 18356149
[TBL] [Abstract][Full Text] [Related]
5. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis.
Huang YS; Dai Y; Yu XF; Bao SY; Yin YB; Tang M; Hu CX
J Gastroenterol Hepatol; 2008 Jan; 23(1):87-94. PubMed ID: 18171346
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
7. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
[TBL] [Abstract][Full Text] [Related]
8. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.
Xu T; Zhu Y; Wei QK; Yuan Y; Zhou F; Ge YY; Yang JR; Su H; Zhuang SM
Carcinogenesis; 2008 Nov; 29(11):2126-31. PubMed ID: 18711148
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
Diao S; Zhang JF; Wang H; He ML; Lin MC; Chen Y; Kung HF
Proteomics; 2010 Oct; 10(20):3723-31. PubMed ID: 20859956
[TBL] [Abstract][Full Text] [Related]
10. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines.
Lin CJ; Gong HY; Tseng HC; Wang WL; Wu JL
Biochem Biophys Res Commun; 2008 Oct; 375(3):315-20. PubMed ID: 18692484
[TBL] [Abstract][Full Text] [Related]
11. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
[TBL] [Abstract][Full Text] [Related]
12. [Construction and identification of the human liver-specific miR-122 expression vector].
Huang Z; Liu C
Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):587-90. PubMed ID: 19637636
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M
Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884
[TBL] [Abstract][Full Text] [Related]
14. [Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR].
Zhao Y; Jia HL; Zhou HJ; Dong QZ; Fu LY; Yan ZW; Sun J; Ren N; Ye QH; Qin LX
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):526-30. PubMed ID: 19912688
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma.
Di Benedetto M; Pineau P; Nouet S; Berhouet S; Seitz I; Louis S; Dejean A; Couraud PO; Strosberg AD; Stoppa-Lyonnet D; Nahmias C
Mol Cell Endocrinol; 2006 Jun; 252(1-2):207-15. PubMed ID: 16650523
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.
Guo Y; Chen Y; Ito H; Watanabe A; Ge X; Kodama T; Aburatani H
Gene; 2006 Dec; 384():51-61. PubMed ID: 16971064
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of cancer-implicated MicroRNA in ovarian cancer.
Bearfoot JL; Choong DY; Gorringe KL; Campbell IG
Clin Cancer Res; 2008 Nov; 14(22):7246-50. PubMed ID: 19010840
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
[TBL] [Abstract][Full Text] [Related]
20. Molecular classification of hepatocellular carcinoma.
Zucman-Rossi J
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S235-41. PubMed ID: 20547309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]